Make Data-Driven Decision-Making a Reality

Finance teams must be able to accurately forecast revenues while reconciling data coming from channel, patient, and operational divisions. Many pharmaceutical manufacturers do not have this alignment in place and as a result, often struggle with net-price transparency and reserve uncertainty during all phases of drug commercialization. Whether you are launching your first therapy or an established manufacturer looking to gain efficiencies in navigating an ever-changing commercial ecosystem, IntegriChain has the tools to help you manage a variety of challenges, including:

• Addressing audit concerns with facts
• Supporting new and innovative payer and channel strategies
• Analytics to convert analogs, demand, and forecast inputs into gross-to-net line items and perform “what if” scenario modeling
• Subject matter expert interpretation of analog data points as well as trusted government and 3rd-party publications

Having worked with hundreds of organizations to address these challenges, IntegriChain has established world-class, curated data, industry best practices, and benchmarks that financial professionals in the pharmaceutical industry can easily leverage via SaaS or as a managed service.